209 related articles for article (PubMed ID: 14691264)
1. Role of serotonin in cocaine effects in mice with reduced dopamine transporter function.
Mateo Y; Budygin EA; John CE; Jones SR
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):372-7. PubMed ID: 14691264
[TBL] [Abstract][Full Text] [Related]
2. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
Budygin EA; John CE; Mateo Y; Jones SR
J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
[TBL] [Abstract][Full Text] [Related]
3. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
[TBL] [Abstract][Full Text] [Related]
4. Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
Carboni E; Spielewoy C; Vacca C; Nosten-Bertrand M; Giros B; Di Chiara G
J Neurosci; 2001 May; 21(9):RC141: 1-4. PubMed ID: 11312315
[TBL] [Abstract][Full Text] [Related]
5. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
6. Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions.
Hall FS; Li XF; Sora I; Xu F; Caron M; Lesch KP; Murphy DL; Uhl GR
Neuroscience; 2002; 115(1):153-61. PubMed ID: 12401330
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.
Sora I; Hall FS; Andrews AM; Itokawa M; Li XF; Wei HB; Wichems C; Lesch KP; Murphy DL; Uhl GR
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5300-5. PubMed ID: 11320258
[TBL] [Abstract][Full Text] [Related]
8. Cocaine, reward, movement and monoamine transporters.
Uhl GR; Hall FS; Sora I
Mol Psychiatry; 2002; 7(1):21-6. PubMed ID: 11803442
[TBL] [Abstract][Full Text] [Related]
9. Cocaine self-administration in dopamine-transporter knockout mice.
Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying the rewarding effects of cocaine.
Hall FS; Sora I; Drgonova J; Li XF; Goeb M; Uhl GR
Ann N Y Acad Sci; 2004 Oct; 1025():47-56. PubMed ID: 15542699
[TBL] [Abstract][Full Text] [Related]
11. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
[TBL] [Abstract][Full Text] [Related]
12. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
[TBL] [Abstract][Full Text] [Related]
13. Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice.
Mead AN; Rocha BA; Donovan DM; Katz JL
Eur J Neurosci; 2002 Aug; 16(3):514-20. PubMed ID: 12193195
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine.
Picciotto MR; Zoli M; Rimondini R; Léna C; Marubio LM; Pich EM; Fuxe K; Changeux JP
Nature; 1998 Jan; 391(6663):173-7. PubMed ID: 9428762
[TBL] [Abstract][Full Text] [Related]
15. Neuroadaptations involved in amphetamine and cocaine addiction.
White FJ; Kalivas PW
Drug Alcohol Depend; 1998; 51(1-2):141-53. PubMed ID: 9716936
[No Abstract] [Full Text] [Related]
16. Increased gabaergic input to ventral tegmental area dopaminergic neurons associated with decreased cocaine reinforcement in mu-opioid receptor knockout mice.
Mathon DS; Lesscher HM; Gerrits MA; Kamal A; Pintar JE; Schuller AG; Spruijt BM; Burbach JP; Smidt MP; van Ree JM; Ramakers GM
Neuroscience; 2005; 130(2):359-67. PubMed ID: 15664692
[TBL] [Abstract][Full Text] [Related]
17. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.
Sora I; Wichems C; Takahashi N; Li XF; Zeng Z; Revay R; Lesch KP; Murphy DL; Uhl GR
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7699-704. PubMed ID: 9636213
[TBL] [Abstract][Full Text] [Related]
18. Hypolocomotor effects of acute and daily d-amphetamine in mice lacking the dopamine transporter.
Spielewoy C; Biala G; Roubert C; Hamon M; Betancur C; Giros B
Psychopharmacology (Berl); 2001 Dec; 159(1):2-9. PubMed ID: 11797063
[TBL] [Abstract][Full Text] [Related]
19. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans.
Volkow ND; Fowler JS; Wang GJ
J Psychopharmacol; 1999 Dec; 13(4):337-45. PubMed ID: 10667609
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
Morice E; Denis C; Giros B; Nosten-Bertrand M
Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
